Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BOLD

Boundless Bio (BOLD) Stock Price, News & Analysis

Boundless Bio logo

About Boundless Bio Stock (NASDAQ:BOLD)

Advanced Chart

Key Stats

Today's Range
$2.36
$2.58
50-Day Range
$59.97
$59.97
52-Week Range
$1.00
$4.72
Volume
96,520 shs
Average Volume
100,927 shs
Market Capitalization
$23.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Consensus Rating
Hold

Company Overview

Boundless Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

BOLD MarketRank™: 

Boundless Bio scored higher than 47% of companies evaluated by MarketBeat, and ranked 568th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Boundless Bio has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Boundless Bio has only been the subject of 3 research reports in the past 90 days.

  • Read more about Boundless Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Boundless Bio are expected to grow in the coming year, from ($3.85) to ($3.35) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Boundless Bio is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Boundless Bio is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Boundless Bio has a P/B Ratio of 0.16. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.91% of the float of Boundless Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Boundless Bio has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in Boundless Bio has recently increased by 21.21%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Boundless Bio does not currently pay a dividend.

  • Dividend Growth

    Boundless Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.91% of the float of Boundless Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Boundless Bio has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in Boundless Bio has recently increased by 21.21%, indicating that investor sentiment is decreasing significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Boundless Bio insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      21.10% of the stock of Boundless Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Read more about Boundless Bio's insider trading history.
    Receive BOLD Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Boundless Bio and its competitors with MarketBeat's FREE daily newsletter.

    BOLD Stock News Headlines

    Boundless Bio Inc News (BOLD) - Investing.com
    A grave, grave error.
    I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
    See More Headlines

    BOLD Stock Analysis - Frequently Asked Questions

    Boundless Bio, Inc. (NASDAQ:BOLD) released its quarterly earnings results on Friday, May, 9th. The biotechnology company reported ($0.71) earnings per share for the quarter, missing the consensus estimate of ($0.68) by $0.03.

    Boundless Bio (BOLD) raised $100 million in an IPO on Thursday, March 28th 2024. The company issued 6,250,000 shares at $16.00 per share.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Boundless Bio investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX), Alphabet (GOOG) and Visa (V).

    Company Calendar

    Last Earnings
    5/09/2025
    Today
    7/05/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED-BIOMED/GENE
    Sub-Industry
    N/A
    Current Symbol
    NASDAQ:BOLD
    Fax
    N/A
    Employees
    207
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $4.00
    High Stock Price Target
    $5.00
    Low Stock Price Target
    $3.00
    Potential Upside/Downside
    +279.1%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.25
    Research Coverage
    4 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$65.36 million
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $6.76 per share
    Price / Book
    0.16

    Miscellaneous

    Free Float
    17,663,000
    Market Cap
    $23.62 million
    Optionable
    No Data
    Beta
    -1.34
    5G Stocks: The Path Forward is Profitable Cover

    Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

    Get This Free Report

    This page (NASDAQ:BOLD) was last updated on 7/5/2025 by MarketBeat.com Staff
    From Our Partners